Molecular biology meets confectionery for functional chocolate

The confectionery sector is witnessing a high-stakes convergence of molecular biology and traditional indulgence with the UK debut of RELEEESE, a functional food brand that aims to redefine the metabolic impact of chocolate.

Backed by the research of German molecular biologist and cancer researcher Dr Johannes Coy, the brand’s flagship product, RELEEESE Chocolate, moves beyond the sugar-free trend toward a model of “intelligent sugar” management.

The launch is rooted in Dr Coy’s breakthrough discovery of the TKTL1 gene, which provides a roadmap for how cells metabolise sugar. While conventional chocolate relies on sucrose, RELEEESE is the first in the world to utilise a patented blend of tagatose and galactose.

These naturally derived sugars, found in milk, possess a significantly lower glycaemic index (GI) than sucrose and carry independently authorised EU and UK health claims for supporting stable blood sugar and promoting tooth health.

The product’s formulation suggests a pivot toward “dual-function” confectionery. Beyond its lower glycaemic profile, the chocolate is high in fibre and Vitamin E. Critically, it incorporates soluble corn fibre, a prebiotic designed to nourish beneficial gut bacteria. This technical profile indicates that RELEEESE is positioning chocolate as a vehicle for metabolic and digestive wellness.

The brand’s commercial strategy targets a highly specific segment of the “Health-Optimiser” market. Priced at a premium £29.99 for a box of 10, the product is currently sold exclusively through a direct-to-consumer (DTC) model. This allows the brand to maintain its positioning as a science-backed specialist item while building a community around Dr Coy’s metabolic research.

However, the brand’s ambitions extend beyond the impulse bar. RELEEESE plans to colonise the wider pantry later this year with the launch of & Bake and Everyday sugar mixtures. This suggests a long-term goal of replacing traditional baking sugars with low-GI alternatives across multiple food categories.

The arrival of RELEEESE signals a maturation of the clean label movement, indicating key takeaways for the industry including:

• The end of simple substitutions: the market is moving away from high-intensity sweeteners and sugar alcohols toward naturally derived monosaccharides that offer a superior taste profile and “rich, creamy” mouthfeel.
• Medical credibility as a USP: by licensing a formulation from a molecular biologist, RELEEESE sets a new standard for functional claims. Producers should expect increased consumer scrutiny regarding how specific ingredients interact with insulin and cellular metabolism.
• The premiumisation of health: the success of a £3.00-per-bar price point confirms that a subset of consumers is willing to pay a significant premium for guilt-free indulgence that is grounded in peer-reviewed science rather than marketing jargon.